Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Georgy Gulbekyan"'
Autor:
Bin Li, Hyunjin Shin, Georgy Gulbekyan, Olga Pustovalova, Yuri Nikolsky, Andrew Hope, Marina Bessarabova, Matthew Schu, Elona Kolpakova-Hart, David Merberg, Andrew Dorner, William L Trepicchio
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0130700 (2015)
Development of drug responsive biomarkers from pre-clinical data is a critical step in drug discovery, as it enables patient stratification in clinical trial design. Such translational biomarkers can be validated in early clinical trial phases and ut
Externí odkaz:
https://doaj.org/article/ff7240e562214215af66645a587a6a86
Autor:
Hyunjin Shin, Bin Li, Olga Pustovalova, David Merberg, Andrew Hope, Marina Bessarabova, Elona Kolpakova-Hart, Andrew Dorner, Georgy Gulbekyan, Matthew Schu, Yuri Nikolsky, William L. Trepicchio
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 6, p e0130700 (2015)
PLoS ONE, Vol 10, Iss 6, p e0130700 (2015)
Development of drug responsive biomarkers from pre-clinical data is a critical step in drug discovery, as it enables patient stratification in clinical trial design. Such translational biomarkers can be validated in early clinical trial phases and ut
Autor:
Andrew Hope, Olga Pustovalova, Bin Li, Matthew Schu, Marina Bessarabova, Hyunjin Shin, Yuri Nikolsky, Georgy Gulbekyan, William L. Trepicchio
Publikováno v:
Molecular Cancer Therapeutics. 12:A37-A37
Discovery of candidate drug sensitivity predictive genomic models using pre-clinical data would significantly advance the ability to timely validate such models in clinical trials and utilize them for selecting appropriate treatments for patients. He